Saskia E. Schols

Internist-hematologist
Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands. Hemophilia Treatment Center Nijmegen – Eindhoven – Maastricht, The Netherlands
Nijmegen, Gelderland, Netherlands

Presentation(s):

• OC 02.2 - PRegnancy and Inherited bleeding DisordErs Study: interim safety analysis after revision of the Dutch guideline.

  Saturday, June 24, 2023
  13:15 – 13:30 ET

• OC 12.2 - Decreased quality of life in non-severe hemophilia patients with an increased bleeding phenotype

  Sunday, June 25, 2023
  11:00 – 11:15 ET

• PB0152 - The spectrum of FVIII-specific antibodies in persons with hemophilia A: a cross-sectional nationwide population study

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0160 - The impact of past inhibitor on health status in patients with haemophilia a in The Netherlands

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0172 - Thrombodynamics: a Novel Assay for Diagnostic Evaluation of Haemophilia A Patients

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0203 - Altered Bleeding Phenotype in Patients with Co-inheritance of Genetic Variants in Thrombosis and Hemostases Genes in Rare Bleeding Disorders

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0205 - High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0824 - Prospective longitudinal evaluation shows increase of VWF and FVIII activity with age in patients with type 1 and 2 Von Willebrand disease

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1157 - Comparison of (semi-)automated thrombin generation platforms for specific coagulopathies with bleeding diathesis.

  Tuesday, June 27, 2023
  18:30 – 19:30 ET